A case of treatment for pulmonary infection caused by multidrug‐resistant Acinetobacter baumannii.

Acinetobacter baumannii is a major pathogen in hospital‐acquired infections notorious for its strong acquired resistance and complex drug resistance mechanisms. Owing to the lack of effective drugs, the mortality rate of extensively drug‐resistant A. baumannii pneumonia can reach as high as 65%. This article analyzes a case where a combination of cefoperazone‐sulbactam, polymyxin B, and minocycline with rifampicin successfully treated XDR‐AB pulmonary infection. Combination therapy is effective and has a particular clinical value. [ABSTRACT FROM AUTHOR]